ClinicalTrials.Veeva

Menu

Full-mouth Electronic Toothbrush Vs. Conventional Electronic Toothbrush

University of Minnesota (UMN) logo

University of Minnesota (UMN)

Status

Enrolling

Conditions

Toothbrush
Plaque
Gingivitis

Treatments

Device: FMET

Study type

Interventional

Funder types

Other

Identifiers

NCT06561204
STUDY00022906

Details and patient eligibility

About

The goal of this randomized, masked-examiner clinical trial is to investigate a full-mouth electronic toothbrush (FMET). The three arms are: 1) FMET + American Dental Association (ADA) approved dentifrice, 2) conventional electronic toothbrush (ETB) + ADA dentifrice and 3) FMET + foam system.

Full description

The primary purpose is to compare the FMET + ADA dentifrice to the conventional ETB + ADA dentifrice. The exploratory aim is to compare the FMET + foam system to both the FMET + ADA dentifrice and conventional ETB + ADA dentifrice. Baseline and 30-day outcome measures will be collected to evaluate the impact on clinical indicators of gingivitis, plaque, and patient perceptions.

Enrollment

105 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • University of Minnesota School of Dentistry patient of record who is 18 years of age or older.
  • Documented periodontal classification of mild to moderate gingivitis (>10% BOP) or documented gingivitis on an intact, reduce, or stable with a history of periodontitis in AxiUm electronic health record (EHR) >10% BOP.
  • A minimum of 25% plaque measured O'Leary plaque score.
  • A minimum of five natural teeth in each quadrant (excluding third molars, dental implants or teeth with more that ½ of natural surface restored).
  • Be willing to abstain from all professional oral hygiene care (prophy/periodontal maintenance) during the study.
  • Be willing to abstain from the use of any other dental cleaning aids (dental floss, water flossers, interdental brushes, dental or tooth picks, mouthwash, etc.) during the study.
  • Access to personal email account and a device connected to the internet to complete questionnaires and communicate with study team.

Exclusion criteria

  • Presence of aggressive, necrotizing, uncommon periodontal disease, or any uncontrolled periodontal condition.
  • Presence of any physical limitation or restriction that might preclude normal oral hygiene procedures (i.e. need another individual to perform oral self-care).
  • Fixed prosthesis (i.e. implant retained denture), orthodontic appliance or under orthodontic treatment.
  • Any medication that may impact periodontal conditions (i.e., phenytoin, calcium antagonists, cyclosporin, warfarin, antimicrobials, or steroids).
  • Have any uncontrolled medical condition or immunocompromised that may impact the study (i.e. uncontrolled diabetes HbA1c > 7, HIV).
  • Pregnant, planning to become pregnant, or unsure of pregnancy status (self-reported)
  • ≥2 weeks of antibiotic use in the past three months. Or antibiotic use in the last six weeks.
  • Cigarette use within the last year
  • Unable to comply with the study protocol

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

105 participants in 3 patient groups

FMET + ADA dentifrice
Experimental group
Description:
Baseline and 30-day outcome measures will be collected to evaluate the impact of FMET + ADA dentifrice on clinical indicators of gingivitis, plaque, and patient perceptions.
Treatment:
Device: FMET
Conventional electronic toothbrush + ADA dentifrice
No Intervention group
Description:
Baseline and 30-day outcome measures will be collected to evaluate the impact of conventional electronic toothbrush + ADA dentifrice on clinical indicators of gingivitis, plaque, and patient perceptions.
FMET + Foam
Other group
Description:
Baseline and 30-day outcome measures will be collected to evaluate the impact of FMET + foam on clinical indicators of gingivitis, plaque, and patient perceptions.
Treatment:
Device: FMET

Trial contacts and locations

1

Loading...

Central trial contact

Danna R Paulson, MS; Michelle C Arnett, MS

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems